DRW Securities’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$201K Buy
+1,043
New +$112K ﹤0.01% 773
2026
Q1
– Sell
-8,442
Closed -$249K – 1582
2025
Q4
$249K Buy
+8,442
New +$229K 0.01% 791
2024
Q2
– Sell
-2,404
Closed -$256K – 591
2024
Q1
$256K Buy
+2,404
New +$242K 0.01% 302
2022
Q2
– Sell
-1,455
Closed -$251K – 311
2022
Q1
$251K Buy
1,455
+370
+34% +$62.3K 0.01% 231
2021
Q4
$276K Buy
+1,085
New +$317K 0.01% 192
2021
Q1
– Sell
-2,366
Closed -$247K – 211
2020
Q4
$247K Buy
+2,366
New +$239K 0.01% 107

Other funds holding MRNA

DRW Securities's MRNA Position: Q3 2026 in Review

DRW Securities opened a new position in Moderna (MRNA) in Q3 2026: 1,043 shares worth $201K. The stake represents ﹤0.01% of the portfolio and ranks #773 among its holdings. This is a return to the name: DRW Securities previously reported a position in MRNA as recently as Q4 2025.

DRW Securities first reported a position in MRNA in Q4 2020 and has held it in 6 quarters since. The position peaked at $276K in Q4 2021. 1,048 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.

  • DRW Securities held 1,043 shares of Moderna worth $201K as of Q3 2026.
  • Moderna was a new DRW Securities position in Q3 2026.
  • Moderna made up ﹤0.01% of DRW Securities's portfolio in Q3 2026, its #773 holding.
  • DRW Securities first reported a position in Moderna in Q4 2020 and has held it in 6 quarters since.
  • DRW Securities's Moderna position peaked at $276K in Q4 2021.
  • 1,048 funds tracked by Wall St. Rank held Moderna as of Q3 2026.

Based on DRW Securities's 13F filing for Q3 2026, filed 13 Nov 2026.